105 related articles for article (PubMed ID: 2674740)
1. Methotrexate therapy in connective tissue diseases: a review of the literature.
Jeurissen ME; Boerbooms AM; van de Putte LB
Neth J Med; 1989 Aug; 35(1-2):44-58. PubMed ID: 2674740
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients.
Wise CM; Vuyyuru S; Roberts WN
J Rheumatol; 1996 Jun; 23(6):1005-10. PubMed ID: 8782131
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with low-dose methotrexate in chronic polyarthritis. Review of the literature].
Rau R
Z Rheumatol; 1986; 45(6):283-95. PubMed ID: 3548154
[TBL] [Abstract][Full Text] [Related]
4. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS
J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758
[TBL] [Abstract][Full Text] [Related]
5. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
[TBL] [Abstract][Full Text] [Related]
7. An update on methotrexate.
Braun J; Rau R
Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
[TBL] [Abstract][Full Text] [Related]
8. [New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
González T; Rodríguez-Lozano B; Hernández-Beriaín JA
Med Clin (Barc); 1991 Oct; 97(11):424-30. PubMed ID: 1961050
[No Abstract] [Full Text] [Related]
9. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying methotrexate-induced pulmonary toxicity.
Kim YJ; Song M; Ryu JC
Expert Opin Drug Saf; 2009 Jul; 8(4):451-8. PubMed ID: 19538103
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha inhibitors in systemic vasculitides and connective tissue diseases.
Lamprecht P
Autoimmun Rev; 2005 Jan; 4(1):28-34. PubMed ID: 15652776
[TBL] [Abstract][Full Text] [Related]
13. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
14. The place of cyclosporine A in the treatment of connective tissue diseases.
Miescher PA; Favre H; Mihatsch MJ; Chatelanat F; Huang YP; Zubler R
Transplant Proc; 1988 Jun; 20(3 Suppl 4):224-37. PubMed ID: 3381275
[No Abstract] [Full Text] [Related]
15. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.
Furst DE
Br J Rheumatol; 1995 Nov; 34 Suppl 2():20-5. PubMed ID: 8535644
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
Ortendahl M; Schettler JD; Fries JF
J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
[TBL] [Abstract][Full Text] [Related]
18. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
Schipper LG; Fransen J; Barrera P; Van Riel PL
Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
